Detection of anti-topoisomerase I autoantibody in patients with silicosis
Environmental Health and Preventive Medicine
;
: 7-10, 2002.
Article
in English
| WPRIM
| ID: wpr-284999
ABSTRACT
<p><b>OBJECTIVES</b>The aim of this study was to detect anti-topoisomerase I (anti-topo I) autoantibodies, which are known to be limited in systemic sclerosis patients, in silicosis patients with no clinical symptoms of autoimmune disease.</p><p><b>METHODS</b>Serum anti-topo I autoantibodies were detected using ELISA. Differences in clinical parameters between patients with and without anti-topo I autoantibodies were analyzed.</p><p><b>RESULTS</b>Seven of 69 patients had anti-topo I autoantibodies. These 7 patients showed elevated PaCO(2) values (P=0.0212), and inverse correlations between serum soluble Fas levels and PaCO(2) values were found.</p><p><b>CONCLUSION</b>Anti-topo I autoantibodies were detected in 10.1% of silicosis patients without any clinical symptoms of autoimmune disease. The findings here suggest that the genesis of anti-topo I autoantibodies might be related to pulmonary involvement or lung fibrosis associated with progression of silicosis.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Diagnostic study
Language:
English
Journal:
Environmental Health and Preventive Medicine
Year:
2002
Type:
Article
Similar
MEDLINE
...
LILACS
LIS